Dudediligence.

Tectonic Therapeutic, Inc

TECXNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$17.7MSep ’24−$12.4MDec ’24−$15.9MMar ’25−$20.0MJun ’25−$19.0MSep ’25−$74.10BDec ’25−$25.2MMar ’26−$22.3MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$118.8M−$105.4M−$44.6M−$58.0M−$84.0M
Net income−$119.1M−$105.9M−$42.8M−$58.0M−$74.15B
Operating cash flow−$98.0M−$97.2M−$40.7M−$59.1M−$60.1M
Free cash flow−$100.5M−$97.5M−$41.0M−$59.2M−$60.3M
Cash$189.6M$92.6M$28.8M$141.2M$253.8M
Debt$15.0M$15.0Mnone on filenone on filenone on file
Shares outstanding43.7M43.9M1.4M14.9M18.7M